BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37132737)

  • 1. Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion.
    Esposito AJ; Imani J; Shrestha S; Bagwe S; Lamattina AM; Vivero M; Goldberg HJ; Rosas IO; Henske EP; El-Chemaly SY
    J Bras Pneumol; 2023; 49(2):e20220356. PubMed ID: 37132737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.
    Hirose M; Matsumuro A; Arai T; Sugimoto C; Akira M; Kitaichi M; Young LR; McCormack FX; Inoue Y
    PLoS One; 2019; 14(2):e0212776. PubMed ID: 30818375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
    Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
    Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of Serum Vascular Endothelial Growth Factor (VEGF-D) and Its Correlation with Functional and Clinical Parameters in Patients with Lymphangioleiomyomatosis from a Brazilian Reference Center.
    Amaral AF; de Oliveira MR; Dias OM; Arimura FE; Freitas CSG; Acencio MMP; de Alvarenga VA; Kairalla RA; Carvalho CRR; Baldi BG;
    Lung; 2019 Apr; 197(2):139-146. PubMed ID: 30623243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
    Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
    Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging biomarkers of lymphangioleiomyomatosis.
    Nijmeh J; El-Chemaly S; Henske EP
    Expert Rev Respir Med; 2018 Feb; 12(2):95-102. PubMed ID: 29171770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of moesin in diagnosing and assessing severity of lymphangioleiomyomatosis.
    Song X; Cai H; Peng W; Chen K; Abuduxukuer Z; Zeng Y; Zhu G; Lu C; Chen Y; Wang J; Ye L; Jin M
    Respir Res; 2024 Jan; 25(1):57. PubMed ID: 38267973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
    Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
    Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis.
    Matthew BP; Hasani AM; Chen YC; Pirooznia M; Stylianou M; Rollison SF; Machado TR; Quade NM; Jones AM; Julien-Williams P; Taveira-DaSilva A; Chen MY; Moss J; Wen H
    Chest; 2021 Jul; 160(1):199-208. PubMed ID: 33549601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
    Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
    Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary lymphangioleiomyomatosis (LAM). Diagnostic usefulness of immunohistochemical markers].
    Serrano Pardo R; Sotelo Rodríguez MT; Alvarez Martínez C; Ballestin Carcavilla C; Larrú Cabrero E
    Arch Bronconeumol; 1998 Nov; 34(10):509-11. PubMed ID: 9881218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis.
    Lamattina AM; Poli S; Kidambi P; Bagwe S; Courtwright A; Louis PH; Shrestha S; Stump B; Goldberg HJ; Thiele EA; Rosas I; Henske EP; El-Chemaly S
    Orphanet J Rare Dis; 2019 Mar; 14(1):72. PubMed ID: 30922357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM).
    Xu KF; Zhang P; Tian X; Ma A; Li X; Zhou J; Zeng N; Gui YS; Guo Z; Feng R; Zhang W; Sun W; Cai B
    Respir Med; 2013 Feb; 107(2):263-8. PubMed ID: 23127572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.
    Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF
    Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.
    Freitas CSG; Baldi BG; Jardim C; Araujo MS; Sobral JB; Heiden GI; Kairalla RA; Souza R; Carvalho CRR
    Orphanet J Rare Dis; 2017 Apr; 12(1):74. PubMed ID: 28427470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
    Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
    Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients.
    Koba T; Arai T; Kitaichi M; Kasai T; Hirose M; Tachibana K; Sugimoto C; Akira M; Hayashi S; Inoue Y
    Respirology; 2018 Mar; 23(3):331-338. PubMed ID: 28960664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response.
    Miller S; Stewart ID; Clements D; Soomro I; Babaei-Jadidi R; Johnson SR
    J Pathol Clin Res; 2020 Jul; 6(3):215-226. PubMed ID: 32352655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report.
    De Rosa N
    Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).
    Baldi BG; Araujo MS; Freitas CS; da Silva Teles GB; Kairalla RA; Dias OM; Pereira DA; Pimenta SP; Carvalho CR
    Lung; 2014 Dec; 192(6):967-74. PubMed ID: 25201087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.